Autonomous Therapeutics Inc

Gelectric Medical Inc is a healthcare technology company based in Silver Spring, MD. Specializing in innovative medical devices and solutions, the company focuses on improving patient care and outcomes through cutting-edge technology. With a commitment to research and development, Gelectric Medical Inc strives to address the evolving needs of the healthcare industry. Their products aim to enhance efficiency and effectiveness in medical settings, ultimately contributing to advancements in patient treatment and care. Generated from their business information

United Therapeutics Corporation is a biotechnology firm focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. The company develops technology platforms for prostacyclin analogs, immunotherapeutic monoclonal antibodies, glycobiology and telemedicine. It performs activities for cardiovascular health, including the development of analogs of the endogenous hormone prostacyclin for the treatment of pulmonary arterial hypertension and critical limb ischemia. United Therapeutics telemedicine services are focused on patients with an array of possible cardiac arrhythmias. The company s IMA therapies are designed to combat ovarian, prostate, breast, lung, pancreatic and colorectal cancers. Its glycobiology compounds target hepatitis C and other infectious diseases. United Therapeutics strategy is balanced among mature programs, pivotal development and early-stage pipeline activities. The company is headquartered in Silver Spring, Md.

PepVax, Inc. is an early stage life sciences technology company based in Silver Spring, MD. They have developed a novel DNA-based drug delivery and development platform for proteins, T-cells, and antibodies to be used in the treatment of cancers, infectious diseases, and genetic disorders. The company has recently achieved significant milestones, including the completion of an efficacy study for their lead candidate, PVX-009, and winning the Best in Show at the Philadelphia 1st Pitch Life Science Competition. With a focus on revolutionizing immunotherapy, PepVax aims to make a real difference in patients' lives by partnering with larger pharmaceutical companies and continuing their growth in the field of biotechnology.Generated from the website